Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose explorationJ Rodon, H Prenen, A Sacher, et al.
ESMO Gastrointestinal Oncology|July 6, 2026
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trialA El Kaddissi, A Vienot, J-D Fumet, et al.
European Journal of Medical Genetics|March 23, 2021
Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patientsS Nambot, C Sawka, G Bertolone, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)A Adenis, J Bennouna, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
ESMO Open|March 5, 2025
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARCC Cuvelier, M Brahmi, I Sobhani, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
European Journal of Medical Genetics|August 31, 2018
Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literatureJ Delanne, S Nambot, A Chassagne, et al.
Pageof 4